The Trump administration is considering narrowly defining gender as a biological, immutable condition determined by genitalia at birth; Medicare for All and single payer healthcare are suddenly popular, but what it means to the politicians embracing the terms are not exactly known; the Trump administration is expected to try to expand religious and moral exemptions for covering birth control in employer health insurance plans.
In the latest effort to reverse to roll back recognition and protections of transgender people under federal civil rights law, the Trump administration is considering narrowly defining gender as a biological, immutable condition determined by genitalia at birth, The New York Times reported. The proposal would unravel a series of decisions by the Obama administration to expand the legal concept of gender in federal programs, including in education and healthcare. HHS is arguing that government agencies needed to adopt an explicit and uniform definition of gender as determined “on a biological basis that is clear, grounded in science, objective and administrable.” But writing in The Atlantic, James Hamblin, MD, said there is a “scientific implausibility and fundamental impossibility of imposing such a definition.”
“Medicare for all” and single-payer healthcare are suddenly popular, but what they mean to the politicians embracing the terms are not exactly known, according to Kaiser Health News. As Republicans sit on the sidelines of attempting to fix a broken healthcare system, more than 120 members of Congress have signed on as cosponsors of a bill called the Expanded and Improved Medicare for All Act, up from 62 in 2016. At least 70 have joined Capitol Hill’s new Medicare for All Caucus. But some worry the terms “Medicare for all” and “single payer” are at risk of becoming empty campaign slogans, because few politicians are speaking precisely about the differences between the 2 ideas.
The Trump administration is expected to try again to issue regulations that would expand religious and moral exemptions for covering birth control in employer health insurance plans, The Washington Post reported. The rules aim to reverse an Affordable Care Act mandate that required coverage. The regulations were filed last week for review with the Office of Management and Budget, indicating that the administration is in the final stages of issuing the expanded exemptions. In December 2017, federal judges in California and Pennsylvania issued preliminary injunctions blocking a previous reversal from taking effect. The Trump administration appealed both injunctions, and the cases are ongoing. A hearing in the California case is scheduled for this week.
CMS' 340B Repayment Proposal May Harm Vulnerable Hospitals, Reward Those With Higher Revenues
April 26th 2024The 340B hospitals not receiving an offsetting lump-sum payment from CMS following 2018-2022 cuts later ruled unlawful are disproportionately rural, publicly owned, and nonacademic, according to a new study.
Read More
Examining Low-Value Cancer Care Trends Amidst the COVID-19 Pandemic
April 25th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the April 2024 issue of The American Journal of Managed Care® about their findings on the rates of low-value cancer care services throughout the COVID-19 pandemic.
Listen
Empowering Community Health Through Wellness and Faith
April 23rd 2024To help celebrate and recognize National Minority Health Month, we are bringing you a special month-long podcast series with our Strategic Alliance Partner, UPMC Health Plan. In the third episode, Camille Clarke-Smith, EdD, MS, CHES, CPT, discusses approaching community health holistically through spiritual and community engagement.
Listen
Kaiser Permanente was hit by a data breach in mid-April, impacting 13.4 million health plan members; GlaxoSmithKline (GSK) sued Pfizer and BioNTech for allegedly infringing on its messenger RNA technology patents in the companies’ COVID-19 vaccines; the CDC announced the first-known HIV cases transmitted via cosmetic injections.
Read More